AKT which is a central mediator of the PI3K pathway can further activate the phosphorylation of mTOR and NF-κB and regulate eukaryotic translation initiation factor 4E and ribosomal protein S6 kinase in cancer [15–17]. Here, AKT1 is linked to cancer.